According to Ruian Gene's announcement, Zhejiang Health Industry Equity Investment Fund, which is responsible for information disclosure, reduced its holdings and passive dilution through centralized bidding from January 10, 2023 to August 10, 2026 due to the expiration of the operating period, reducing the shareholding ratio from 11.25% to 10%. Before this equity change, it held 6251,559 shares, and 5585,464 shares after the change. In addition, Zhejiang Health plans to continue to reduce its holdings by no more than 1675,675 shares from July 14 to October 13, 2026, accounting for no more than 3% of the total share capital. As of the disclosure date of the report, the plan to reduce its holdings has not been completed.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.